During the past decade, California Heart Specialists conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Heart Specialists" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "American Regent, Inc." with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Heart Specialists" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "California Heart Specialists" are "Heart Failure" (4 trials), "Cardiovascular Disease" (1 trials), "High Cardiovascular Risk" (1 trials), "Hyperlipidemia" (1 trials) and "Iron-deficiency" (1 trials). Many other conditions were trialed in "California Heart Specialists" in a lesser frequency.

Most popular intervention types in "California Heart Specialists" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Ferric Carboxymaltose" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "California Heart Specialists" are 6 trials for "All" genders.

Currently, there are NaN active trials in "California Heart Specialists". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in California Heart Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in California Heart Specialists, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".